Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma

Stopped Due to the changes of standard of care and the slow recruitment of participants.

Conditions

• Multiple Myeloma

Interventions

• DRUG: Radium-223 dichloride (Xofigo, BAY88-8223)
• DRUG: Placebo
• DRUG: Bortezomib
• DRUG: Dexamethasone

Sponsor

Bayer